Zuzana Bielcikova

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Venues

The oncologist

Cancers

Therapeutic advances in medical oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Zuzana Bielcikova, Milos Holanek, Iveta Selingerova, Ondrej Sorejs, Iveta Kolarova, Renata Soumarova, Jan Proks, Lucie Reifova, Vlastimila Cmejlova, Lenka Linkova, Michaela Zabojnikova, Martina Chodacka, Lucie Janovska, Lenka Lisnerova, Karolina Kasparova, Denisa Pohankova, Lubos Petruzelka
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The oncologist 29 (6) (2024)
Zuzana Bielcikova, Milos Holanek, Iveta Selingerova, Ondrej Sorejs, Iveta Kolarova, Renata Soumarova, Jan Proks, Lucie Reifova, Vlastimila Cmejlova, Lenka Linkova, Michaela Zabojnikova, Martina Chodacka, Lucie Janovska, Lenka Lisnerova, Karolina Kasparova, Denisa Pohankova, Lubos Petruzelka
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The oncologist 29 (6) (2024)
Zuzana Bielcikova, Milos Holanek, Iveta Selingerova, Ondrej Sorejs, Iveta Kolarova, Renata Soumarova, Jan Proks, Lucie Reifova, Vlastimila Cmejlova, Lenka Linkova, Michaela Zabojnikova, Martina Chodacka, Lucie Janovska, Lenka Lisnerova, Karolina Kasparova, Denisa Pohankova, Lubos Petruzelka
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The oncologist 29 (6) (2024)
Zuzana Bielcikova, Milos Holanek, Iveta Selingerova, Ondrej Sorejs, Iveta Kolarova, Renata Soumarova, Jan Proks, Lucie Reifova, Vlastimila Cmejlova, Lenka Linkova, Michaela Zabojnikova, Martina Chodacka, Lucie Janovska, Lenka Lisnerova, Karolina Kasparova, Denisa Pohankova, Lubos Petruzelka
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The oncologist 29 (6) (2024)
Zuzana Bielcikova, Milos Holanek, Iveta Selingerova, Ondrej Sorejs, Iveta Kolarova, Renata Soumarova, Jan Proks, Lucie Reifova, Vlastimila Cmejlova, Lenka Linkova, Michaela Zabojnikova, Martina Chodacka, Lucie Janovska, Lenka Lisnerova, Karolina Kasparova, Denisa Pohankova, Lubos Petruzelka
Treatment and Prognosis of Male Breast Cancer: A Multicentric, Retrospective Study Over 11 Years in the Czech Republic. The oncologist (2024)
Martina Zimovjanova, Zuzana Bielcikova, Michaela Miskovicova, Michal Vocka, Anna Zimovjanova, Marian Rybar, Jan Novotny, Lubos Petruzelka
Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic. Cancers 15 (4) (2023)
Jiri Neuzil, Jakub Rohlena, Lukas Werner, Zuzana Bielcikova
MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29 , 115-126. Cancers 15 (18) (2023)
Martina Zimovjanova, Zuzana Bielcikova, Michaela Miskovicova, Michal Vocka, Anna Zimovjanova, Marian Rybar, Jan Novotny, Lubos Petruzelka
Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic. Cancers 15 (4) (2023)
Martina Zimovjanova, Zuzana Bielcikova, Michaela Miskovicova, Michal Vocka, Anna Zimovjanova, Marian Rybar, Jan Novotny, Lubos Petruzelka
Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female BRCA1 and BRCA2 Carriers: A Single Institution Experience in the Czech Republic. Cancers 15 (4) (2023)
Zuzana Bielcikova, Lukas Werner, Jan Stursa, Vladimir Cerny, Ludmila Krizova, Jan Spacek, Stanislav Hlousek, Michal Vocka, Olga Bartosova, Michal Pesta, Katarina Kolostova, Petr Klezl, Vladimir Bobek, Jaroslav Truksa, Sona Stemberkova-Hubackova, Lubos Petruzelka, Pavel Michalek, Jiri Neuzil
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial. Therapeutic advances in medical oncology 15 (2023)
Eliska Vacurova, Jaroslava Trnovska, Petr Svoboda, Vojtech Skop, Vendula Novosadova, David Pajuelo Reguera, Silvia Petrezsélyová, Benoit Piavaux, Berwini Endaya, Frantisek Spoutil, Dagmar Zudova, Jan Stursa, Magdalena Melcova, Zuzana Bielcikova, Lukas Werner, Jan Prochazka, Radislav Sedlacek, Martina Huttl, Sona Stemberkova Hubackova, Martin Haluzík, Jiri Neuzil
Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice. Nature communications 13 (1) (2022)

Zuzana Bielcikova.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zuzana Bielcikova